| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/21/2007 | CN1918164A Azabicyclic heterocycles as cannabinoid receptor modulators |
| 02/21/2007 | CN1918163A Fused pyrrolocarbazoles and methods for the preparation thereof |
| 02/21/2007 | CN1918162A Novel fused pyrrolocarbazoles |
| 02/21/2007 | CN1918159A Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1) |
| 02/21/2007 | CN1918158A Compounds and compositions as protein kinase inhibitors |
| 02/21/2007 | CN1918137A Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1917881A Novel phenylalanine derivatives |
| 02/21/2007 | CN1915995A S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method |
| 02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179921 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
| 02/20/2007 | US7179908 Reacting glycoluril with formaldehyde; separation, purification |
| 02/20/2007 | US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 02/20/2007 | US7179809 2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
| 02/20/2007 | US7179805 Microbiocides; bactericides |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor |
| 02/15/2007 | WO2007019083A1 Pyrimidine compounds as serotonin receptor modulators |
| 02/15/2007 | WO2007018998A2 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 02/15/2007 | WO2007018818A1 A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor |
| 02/15/2007 | WO2007018808A2 Methods and intermediates for the synthesis of porphyrins |
| 02/15/2007 | WO2007018807A2 Methods and intermediates for the synthesis of porphyrins |
| 02/15/2007 | WO2007018660A2 Gabaergic imidazobenzodiazepine derivatives to treat memory deficits |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007017698A1 Preparation of diazapentalene derivatives via epoxydation of dihydropyrroles |
| 02/15/2007 | WO2007017678A1 Pyrazolo[1,5-a] pyrimidine compounds and pharmaceutical compositions containing them |
| 02/15/2007 | WO2007017468A2 Preparation of a 7h-pyrr0l0 [2 , 3-d] pyrimidine derivative |
| 02/15/2007 | WO2007017096A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 02/15/2007 | WO2007017083A1 Pyrazole derivatives having tyrosinkinase activity |
| 02/15/2007 | WO2006114405A3 Use of 5-alkyl-6-phenylalkyl-7-amino-azolopyrimidines, novel azolopyrimidines, methods for the production thereof, and agents containing the same |
| 02/15/2007 | WO2006067614B1 Heteroaromatic derivatives useful as anticancer agents |
| 02/15/2007 | US20070037977 Substituted-1, 3-oxathiolanes and substituted-1, 3-dioxolanes with antiviral properties |
| 02/15/2007 | US20070037975 Substituted-1,3-oxathiolanes and substituted-1, 3-dioxolanes with antiviral properties |
| 02/15/2007 | US20070037971 Process for desilylation of carbapenem intermediates |
| 02/15/2007 | US20070037867 Antihepatitis c virus agent and anti-hiv agent |
| 02/15/2007 | US20070037851 Inhibits binding of CCR3 ligands such as eotaxins to their target cells; inhibits physiological effects of binding; therapeutic and prophylactic agents for asthma, rhinitis, dermatitis, urticaria, conjunctivitis, inflammatory bowel; tissue infiltration of eosinophils, basophils, activated T cells |
| 02/15/2007 | US20070037845 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors, and intermediates thereof |
| 02/15/2007 | US20070037838 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d 6,5-d']dipyrimidyne and 10-aza-analogue thereof |
| 02/15/2007 | US20070037834 Bicyclic pyrimidine derivatives |
| 02/15/2007 | US20070037829 e.g. trans-(4-Phenethyloxy-cyclohexyl)-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine; neurodegenerative disorders, analgesic, antidepressant, anxiolytic agent; Parkinson's disease, Alzheimer's disease, epilepsy, ischemic brain injury, stroke; with other active ingredients |
| 02/15/2007 | US20070037828 Pyrazolopyrimidines |
| 02/15/2007 | US20070037824 Enzyme inhibitors from pyrazolo[1,5a]pyrimidine as enzyme inhibitors |
| 02/15/2007 | US20070037817 Acetylenic piperazines as metabotropic glutamate receptor antagonists |
| 02/15/2007 | US20070037816 Bicyclic piperazines as metabotropic glutatmate receptor antagonists |
| 02/15/2007 | US20070037815 Novel pharmaceutical compounds |
| 02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037790 Bicyclo-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/15/2007 | US20070037787 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 02/15/2007 | US20070037771 Process for preparing branched ribonucleosides from 1,2-anhydroribofuranose intermediates |
| 02/15/2007 | US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 02/15/2007 | US20070036714 Porphyrin derivatives, methods for obtaining same, and use thereof in radioimmunotherapy |
| 02/15/2007 | CA2618524A1 Pyrazole derivatives having tyrosine kinase activity |
| 02/15/2007 | CA2618217A1 Marqueurs, leur procede de fabrication et leurs applications |
| 02/15/2007 | CA2618112A1 Pyridone compound |
| 02/15/2007 | CA2617760A1 Pyrimidine compounds as serotonin receptor modulators |
| 02/15/2007 | CA2617720A1 Preparation of a 7h-pyrr0l0 [2 , 3-d] pyrimidine derivative |
| 02/15/2007 | CA2617289A1 Process for preparing an angiotensin ii receptor antagonist |
| 02/15/2007 | CA2616428A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 02/15/2007 | CA2616303A1 Preparation of diazapentalene derivatives via epoxydation of dihydropyrroles |
| 02/15/2007 | CA2616020A1 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 02/15/2007 | CA2607226A1 Gabaergic agents to treat memory deficits |
| 02/14/2007 | EP1752457A1 Fused heterocyclic compound |
| 02/14/2007 | EP1752455A2 Chemokine receptor binding heterocyclic compounds |
| 02/14/2007 | EP1751164A1 3,6-diazabicyclos[3.1.1]heptane derivatives with analgesic activity |
| 02/14/2007 | EP1751163A2 Compounds having affinity for dopamine d3 receptor and uses thereof |
| 02/14/2007 | EP1751162A1 Triazolopyrimidine compounds and their use for controlling pathogenic fungi |
| 02/14/2007 | EP1751161A1 Diazaindole-dicarbonyl-piperazinyl antiviral agents |
| 02/14/2007 | EP1751160A1 6-(2,3,6-trifluorophenyl)-triazolopyrimidines for combating pathogenic fungi |
| 02/14/2007 | EP1751152A2 Azinyl imidazoazine and azinyl carboxamide |
| 02/14/2007 | EP1751147A1 New amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride) and process to produce the same |
| 02/14/2007 | EP1751142A1 Pyrimidines derivatives for the treatment of abnormal cell growth |
| 02/14/2007 | EP1751130A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 02/14/2007 | EP1750727A2 Kinase modulators and methods of use |
| 02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/14/2007 | EP1670313B1 Fungicidal mixtures |
| 02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 02/14/2007 | EP1532121B1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 02/14/2007 | EP1523485B1 3-furanyl analogs of toxoflavine as kinase inhibitors |
| 02/14/2007 | EP1406903B1 Fungicidal triazolopyrimidines, method for the production thereof and use thereof in controlling noxious fungi and agents containing said compounds |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 02/14/2007 | EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 02/14/2007 | EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 02/14/2007 | EP1259234B9 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 02/14/2007 | EP0820283B1 Lactacystin analogs |
| 02/14/2007 | CN1914738A 有机薄膜晶体管 The organic thin film transistor |
| 02/14/2007 | CN1914225A HCV NS-3 serine protease inhibitors |
| 02/14/2007 | CN1914209A Diaza- or thiazadione derivatives with neuroprotective activity |
| 02/14/2007 | CN1914208A Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalklymine]-pyrimido[1,2a]pyrimidin-6-one derivatives |
| 02/14/2007 | CN1914207A Azepinoindole derivatives as pharmaceutical agents |
| 02/14/2007 | CN1913778A Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911929A Meso position-tetra phenyl tetra phenanthro porphyrin derivetive and its preparation method |
| 02/14/2007 | CN1911915A Lactam compound and medicinal use thereof |